ERBB2 and breast carcinoma: Inducing apoptosis and completely eliminating ErbB2‐expressing MDA‐MB453 SKBR3 breast carcinoma cell lines (in vitro) and inhibiting the in vivo growth of ErbB2‐expressing tumour cells by NK‐92 scFv(FRP5)‐zeta cells